Literature DB >> 17961981

The effect of left ventricular size on right ventricular hemodynamics in pediatric survivors with hypoplastic left heart syndrome.

Jon Wisler1, Philip R Khoury, Thomas R Kimball.   

Abstract

BACKGROUND: Outcome status in patients with hypoplastic left heart syndrome (HLHS) is partially dependent on right ventricular (RV) systolic function. In other disease states, ventricular function is impacted by anatomy and physiology of the contralateral ventricle. In HLHS, it is suggested that a relatively larger left ventricular (LV) size may negatively impact RV function because it becomes a "passenger" without providing any systolic or diastolic physiologic benefit. The purpose of this study was to determine whether LV size adversely affects RV systolic function in surviving patients with HLHS.
METHODS: The hospital database was searched for all patients with HLHS and technically adequate echocardiograms born in the last 6 years and who had survived at least the Norwood procedure. LV size was assessed by echocardiographic measurement of LV end-diastolic short-axis and apical area. RV function was assessed by short-axis and apical fractional area change as well as the myocardial performance index (Tei). Measurements were made at up to 4 time points depending on duration of follow-up (1 - pre-Norwood; 2 - pre-Glenn; 3 - pre-Fontan; and 4- post-Fontan).
RESULTS: A total of 48 patients were studied. LV size showed sufficient variability in the patient population (1.0-21 cm(2)/body surface area, pre-Norwood). RV function tended to worsen across the time periods but these changes did not reach statistical significance. Regression analysis showed no effect of LV size on RV function before Norwood operation. Significant correlations existed between LV size indices and RV functional indices before Glenn shunt but these were inconsistent in the direction of their effect. Only before Fontan operation did the correlation between LV size and RV function become both consistent and statistically significant; specifically larger LV size correlated significantly with poor RV systolic function (short-axis RV fractional area change vs LV area r = -0.4, P = .03 and RV Tei vs LV area r = 0.5, P = .02). These relationships were not apparent after Fontan operation.
CONCLUSION: In surviving patients with HLHS, larger LV size does not seem to negatively impact RV function before or after Norwood procedure nor does it seem to have an adverse effect on RV function chronically (after Fontan). However, further study with larger population size will be necessary to see whether these findings remain negative and are true for nonsurvivors as well.

Entities:  

Mesh:

Year:  2007        PMID: 17961981     DOI: 10.1016/j.echo.2007.09.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  9 in total

1.  Relation of size of secondary ventricles to exercise performance in children after fontan operation.

Authors:  Ashwin Prakash; Thomas G Travison; Mark A Fogel; Lynne M Hurwitz; Andrew J Powell; Beth F Printz; Michael D Puchalski; Girish S Shirali; Shi-Joon Yoo; Tal Geva
Journal:  Am J Cardiol       Date:  2010-12-01       Impact factor: 2.778

2.  The Impact of the Left Ventricle on Right Ventricular Function and Clinical Outcomes in Infants with Single-Right Ventricle Anomalies up to 14 Months of Age.

Authors:  Meryl S Cohen; Nicholas Dagincourt; Victor Zak; Jeanne Marie Baffa; Peter Bartz; Andreea Dragulescu; Gul Dudlani; Heather Henderson; Catherine D Krawczeski; Wyman W Lai; Jami C Levine; Alan B Lewis; Rachel T McCandless; Richard G Ohye; Sonal T Owens; Steven M Schwartz; Timothy C Slesnick; Carolyn L Taylor; Peter C Frommelt
Journal:  J Am Soc Echocardiogr       Date:  2018-07-03       Impact factor: 5.251

3.  Assessment of ventricular function and dyssynchrony before and after stage 2 palliation of hypoplastic left heart syndrome using two-dimensional speckle tracking.

Authors:  Colin Petko; Ulrike Hoffmann; Peter Möller; Jens Scheewe; Hans-Heiner Kramer; Anselm Uebing
Journal:  Pediatr Cardiol       Date:  2010-08-11       Impact factor: 1.655

4.  Right ventricular performance in the fetus with hypoplastic left heart syndrome.

Authors:  Anita Szwast; Zhiyun Tian; Margaret McCann; Denise Donaghue; Jack Rychik
Journal:  Ann Thorac Surg       Date:  2009-04       Impact factor: 4.330

Review 5.  Left ventricle after palliation of hypoplastic left heart syndrome: friend, fiend, or innocent bystander?

Authors:  Jeffrey H Shuhaiber; Frank A Pigula
Journal:  Pediatr Cardiol       Date:  2013-03-22       Impact factor: 1.655

6.  Negative Impact of the Left Ventricular Remnant Morphology on Systemic Right Ventricular Myocardial Deformation in Hypoplastic Left Heart Syndrome.

Authors:  Alan P Wang; Angela M Kelle; Meredith Hyun; Chelsea L Reece; Phillip M Young; Patrick W O'Leary; M Yasir Qureshi
Journal:  Pediatr Cardiol       Date:  2020-10-26       Impact factor: 1.655

7.  Serial Assessment of Right Ventricular Deformation in Patients With Hypoplastic Left Heart Syndrome: A Cardiovascular Magnetic Resonance Feature Tracking Study.

Authors:  Luca Mitch Kanngiesser; Sandra Freitag-Wolf; Simona Boroni Grazioli; Dominik Daniel Gabbert; Jan Hinnerk Hansen; Anselm Sebastian Uebing; Inga Voges
Journal:  J Am Heart Assoc       Date:  2022-04-27       Impact factor: 6.106

8.  Myocardial Deformation in Fontan Patients Assessed by Cardiac Magnetic Resonance Feature Tracking: Correlation with Function, Clinical Course, and Biomarkers.

Authors:  Alessia Callegari; Simona Marcora; Barbara Burkhardt; Michael Voutat; Christian Johannes Kellenberger; Julia Geiger; Emanuela Regina Valsangiacomo Buechel
Journal:  Pediatr Cardiol       Date:  2021-07-27       Impact factor: 1.655

9.  Evaluation of right ventricular function in fetal hypoplastic left heart syndrome using spatio-temporal image correlation (STIC).

Authors:  Jing Zhang; Qichang Zhou; Yili Zhao; Qinghai Peng; Zheli Gong; Xiangdang Long
Journal:  Cardiovasc Ultrasound       Date:  2016-04-11       Impact factor: 2.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.